Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
6,141.58
7,920.52
9,508.30
8,857.56
7,509.61
6,065.07
6,851.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,141.58
7,920.52
9,508.30
8,857.56
7,509.61
6,065.07
6,851.97
Raw Material Cost
1,429.68
1,779.93
1,909.45
1,664.66
1,391.00
1,237.39
1,190.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
1,013.97
763.77
740.10
891.98
782.59
782.23
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.32
28.40
18.59
31.24
35.48
33.59
31.17
Selling and Distribution Expenses
2,489.45
3,287.49
4,300.51
4,430.56
3,961.18
3,228.96
3,647.53
Other Expenses
32.61
-63.69
-36.78
-26.25
-44.08
-60.26
-62.35
Total Expenditure (Excl Depreciation)
4,257.53
5,472.85
6,624.48
6,604.07
5,838.86
4,679.89
5,028.00
Operating Profit (PBDIT) excl Other Income
1884.1
2447.7000000000003
2883.8
2253.5
1670.6999999999998
1385.2
1824
Other Income
280.01
481.94
414.24
292.12
200.22
112.00
113.21
Operating Profit (PBDIT)
2,444.77
3,216.37
3,602.73
2,861.58
2,172.91
1,785.25
2,150.75
Interest
12.32
28.40
18.59
31.24
35.48
33.59
31.17
Exceptional Items
41.31
98.92
14.60
-7.32
114.13
20.17
8.59
Gross Profit (PBDT)
4,711.91
6,140.59
7,598.85
7,192.89
6,118.60
4,827.69
5,661.37
Depreciation
311.51
308.65
304.11
315.88
301.80
288.07
235.04
Profit Before Tax
2,162.26
2,978.25
3,294.63
2,507.15
1,949.76
1,483.75
1,893.14
Tax
383.99
441.54
470.03
336.20
233.22
206.29
270.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,777.85
2,531.55
2,822.78
2,170.75
1,719.18
1,277.21
1,622.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,777.85
2,531.55
2,822.78
2,170.75
1,719.18
1,277.21
1,622.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.41
5.15
4.28
0.97
-1.96
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,778.26
2,536.71
2,827.06
2,171.72
1,717.22
1,277.21
1,622.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
0.0
0.0
0.0
0.0
0.0
Reserves
14,605.55
14,701.85
13,349.44
11,337.27
9,116.88
7,763.18
6,104.43
Earnings per share (EPS)
1.94
2.76
3.08
2.39
1.91
1.53
1.99
Diluted Earnings per share
1.94
2.76
3.08
2.39
1.91
1.53
1.99
Operating Profit Margin (Excl OI)
30.18%
30.63%
30.34%
25.44%
22.25%
22.84%
26.31%
Gross Profit Margin
40.28%
41.5%
37.85%
31.87%
29.98%
29.21%
31.06%
PAT Margin
28.95%
31.96%
29.69%
24.51%
22.89%
21.06%
23.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -22.46% vs -16.70% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -29.90% vs -10.27% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -20.83% vs -14.24% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -56.69% vs 52.69% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Hubei Jumpcan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
6,141.58
0
6,141.58
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,141.58
0
6,141.58
Raw Material Cost
1,429.68
0
1,429.68
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.32
0
12.32
Selling and Distribution Expenses
2,489.45
0
2,489.45
Other Expenses
32.61
0.00
32.61
Total Expenditure (Excl Depreciation)
4,257.53
0
4,257.53
Operating Profit (PBDIT) excl Other Income
1,884.06
0.00
1,884.06
Other Income
280.01
0
280.01
Operating Profit (PBDIT)
2,444.77
0
2,444.77
Interest
12.32
0
12.32
Exceptional Items
41.31
0
41.31
Gross Profit (PBDT)
4,711.91
0
4,711.91
Depreciation
311.51
0
311.51
Profit Before Tax
2,162.26
0
2,162.26
Tax
383.99
0
383.99
Provisions and contingencies
0
0
0.00
Profit After Tax
1,777.85
0
1,777.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,777.85
0
1,777.85
Share in Profit of Associates
0
0
0.00
Minority Interest
0.41
0
0.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,778.26
0
1,778.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
14,605.55
0
14,605.55
Earnings per share (EPS)
1.94
0
1.94
Diluted Earnings per share
1.94
0
1.94
Operating Profit Margin (Excl OI)
30.18%
0%
0.00
30.18%
Gross Profit Margin
40.28%
0%
0.00
40.28%
PAT Margin
28.95%
0%
0.00
28.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 614.16 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -22.46% vs -16.70% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 177.83 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -29.90% vs -10.27% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 216.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -20.83% vs -14.24% in Dec 2024
Annual - Interest
Interest 1.23 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -56.69% vs 52.69% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.18%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






